Contact Us   |   Print Page   |   Sign In   |   Join
Coronavirus Resource Center



MichBio is working closely with partners in the Governor's Office, public health and homeland security agencies, legislative branch, industry, health systems and academia in response to the COVID-19 pandemic. We encourage all Michigan residents to actively participate in the efforts to combat the virus.



CDC - The Centers for Disease Control and Prevention response updates


MDHHS - Michigan Department of Health and Human Services is providing Michigan updates


WHO - World Health Organization is providing daily situation reports


JHU - Johns Hopkins University maintains an interactive map



The stay-at-home executive order (EO) issued by Governor Whitmer has many life science organizations questioning whether they can continue operating. The short answer is yes, as the EO references the federal guidance issued by the U.S. Department of Homeland Security, Cyber and Infrastructure (CISA) that lists essential businesses - including virtually all healthcare and hospital services, life science research, medical device organizations and manufacturers, all organization involved in the medical or healthcare supply chains, agriculture and more. MichBio is awaiting clarity and greater specificity from the Governor's Office with regards to exemptions for the bio-industry, as has been provided in a few other states. We will announces any clarifications as soon as we a receive response from authorities. If you have questions or are in need of assistance, please contact Stephen Rapundalo at


5/16/2020 UPDATE

On Friday, May 15, 2020 Governor Whitmer signed an Executive Order allowing laboratory work to resume. The Executive Order outlines specific safety protocols and procedures that are required for businesses as they reopen including, dedicated entry points and times, closing of all open office spaces (conference rooms, cafeterias, etc), conducting daily employee screenings, distribution of face masks, among others. See the full list of requirements here.


5/4/2020 UPDATE

As of right now the Stay Home Executive Order in Michigan is set to expire in the coming weeks, which means many businesses will be ramping back up and restarting operations. This presentation from Boston Consulting Group gives a lot of useful information for companies looking to the future and wanting guidance on safely opening their businesses.


3/26/2020 UPDATE

The latest EO from Gov. Whitmer specifically cites, “workers conducting research critical to COVID-19 response” and “workers necessary for the manufacturing of materials and products needed for medical supply chains” are identified as Critical Infrastructure Workers in the subsections related to Health Care/Health Professionals and Critical Manufacturing. MichBio continues to advocate and seek a letter that provides more specific guidance for MichBio members and Michigan’s bio-industry, particularly regarding research and development as has been issued in a few other states like IL. MichBio hopes that this update is helpful in the interim.



Visit the Dykema COVID-19 Resource Center for the latest information on the legal ramifications of the rulings, directives, and legislation related to the coronavirus pandemic.


MichBio has been working feverishly for the last two weeks with the Governor’s Office and the Michigan State Police’s Homeland Security division to identify vendors, suppliers, manufacturers, donors and other resources that can help meet the need for critical medical products. We continue to facilitate numerous connections within Michigan and globally that are leading to successful supply outcomes for health systems and others who are in desperate need. To make it easier, several organizations noted below have set up easy-to-use portals where companies and individuals can submit their capabilities, capacities, and other key information. Notwithstanding, MichBio is happy to receive additional leads and ideas that can support our ability to connect the dots for those here in Michigan.



  • BIO (Biotechnology Innovation Organization) has launched a Coronavirus Hub where suppliers, manufacturers, healthcare professionals, health systems, and others can submit their production capabilities and/or their needs to be matched with a supplier.
  • Contact MichBio directly with your needs or capabilities. In collaboration with organizations in Michigan and throughout the region, MichBio is working to pair organizations with supply or capability with those who have urgent need.
  • FDA has been monitoring the drug supply chain and communicating with manufacturers related to the possibility of shortages of drugs, API, and related supplies. Shortages or supply issues should be reported to the FDA through the CDER Direct NextGen Portal. Additional information on reporting shortages or supply issues is available from the FDA.

  • Healthcare Ready (formerly RxResponse), is an independent non-profit that serves as a convener of public and private sector partners to strengthen healthcare systems before, during, and after disasters.  Healthcare Ready is gathering information from organizations, including information on the current demands of pharmaceuticals and personal protective equipment (PPE). To respond to their survey on supply chain issues, click here.

  • Get Us PPE is a group dedicated solely to connecting healthcare workers and those in need on Personal Protection Equipment with suppliers - enter your needs or capabilities into their database or learn where to take supply donations.


Submit to the U.S. Government Portal. The U.S. government, in response to the COVID-19 outbreak, seeks information from stakeholders on available medical countermeasures in development. We are particularly interested in products and technologies that have progressed into or beyond non-clinical trials, have established large-scale cGMP manufacturing capability, or utilize an approved platform. Information regarding diagnostics, therapeutics, vaccines, and other products or technologies relevant to addressing this outbreak are sought.

At this time, we ask for a brief description of your product or technology, accompanied by a slide deck, manuscript, publications, or other non-confidential information of your choosing. Please note that while we will use any information you present as market research, submission is no guarantee of a meeting or funding and your submission will be shared across U.S. Government agencies involved in COVID-19 medical countermeasure research and development.  Only U.S. government officials are invited to join a CoronaWatch meeting, and are bound by law to maintain confidentiality of what is presented and discussed.

Ideal technologies and products would (but are not required to) be:

    • Relevant to the U.S. government COVID-19 medical countermeasure research and development efforts and/or Emerging Infectious Disease rapid response capabilities
    • Utilize an already-approved platform, have non-clinical data suggesting efficacy, and/or have significant manufacturing capability
    • Fully owned or licensed by your organization (you have full IP rights and/or freedom to operate)



FDA has created a special emergency program for possible therapies, the Coronavirus Treatment Acceleration Program (CTAP). It uses every available method to move new treatments to patients as quickly as possible, while at the same time finding out whether they are helpful or harmful. We continue to support clinical trials that are testing new treatments for COVID so that we gain valuable knowledge about their safety and effectiveness. Learn more.



ID Ventures, with lead support from the MEDC, has launched a fund to help stabilize Michigan startups impacted by the economic downturn caused by the COVID-19 pandemic, extend their runway, and put them on a path to scale when the downturn subsides. Learn more.



Michigan has become a hot-bed of COVID-19 infections, which means there is a massive need for volunteers around the state for everything from donations of supplies and blood, to medical expertise and help providing services to elderly or at risk members of the community. Sign up to volunteer.



Scientists and lab workers around the country with skills relevant to the COVID-19 pandemic can add their name to a national database of those who are ready and willing to deploy their advanced skills, expertise, and access to reagents/equipment toward the fight against the virus in their local communities. The list is currently being used by hospitals and labs looking to scale up testing capabilities or other functions directly related to COVID-19. Add your information here.


Personal Protection Equipment (PPE)

  • Surgical/procedure masks

  • N95/N99 masks (respirators)

  • Face masks with integrated shield

  • PAPRs

  • Goggles

  • Gloves

  • Protective suits/gowns

  • Booties / shoe covers

  • Head covers

  • Hand sanitizer

  • Sanitizing wipes

Professional Resources

  • Lab Tech

  • Registered Nurse

  • Physician/Medical Doctor

  • Pharmacist

 Hospital Supplies

  • Ventilators, PEEP

  • Stretchers/beds

  • Hospital gowns

  • Endotracheal tubes

  • Vital sign monitors

  • Thermometers


Diagnostic Supplies and Instruments

  • Roche MagNA Pure Compact RNA Isolation Kits

  • Roche MagNA Pure Compact Nucleic Acid Isolation Kits

  • Roche MagNA Pure 96 DNA and Viral NA Small Volume Kits

  • Roche MagNA Pure systems

  • Roche 480Z

  • ABI 7500DX

  • Qiagen EZ1 Advanced XL

  • QIAcube/QIAcube Connect

  • cobas omni Wash Reagent 6997503190

  • cobas omni Lysis Reagent  6997538190

  • cobas omni MGP Reagent 6997546190

  • cobas omni Specimen Diluent 6997511190

  • cobas NHP Negative Control Kit 7002220190

  • cobas omni Pipette Tips 5534925001

  • cobas omni Processing Plate 5534917001

  • cobas omni Amplification Plate 5534941001

  • 6800 biohazard bags 7435967001

 Lab Supplies

  • UVT 3ML with flocked flex minitip

  • 1.5ml swab microtiped flocked

  • 6in swab Darcon

  • Medium 2% FBS STD REFEED ML

  • Sample collection supplies (sterile swabs, tubes, media)

  • MicroAmp™ Optical 384-Well Reaction Plate with Barcode

  • MicroAmp™ Fast Optical 96-Well Reaction Plate 0.1mL

  • RNAse Away 6-pack

  • RNeasy Mini Kit

  • TaqMan™ Fast Advanced Master Mix

  • BD Universal Viral Transport for Viruses, Chlamydiae, Mycoplasmas, and Ureaplasmas

  • 0.2 mL PCR 8-tube Strip with Indiv. Attached Dome Caps

  • QIAamp MinElute Virus Spin Kit

  • Viral RNA Isolation Kits

  • QIAamp® Viral RNA Mini Kits

  • QIAamp® MinElute Virus Spin Kit or RNeasy® Mini Kits (QIAGEN

  • EZ1 DSP Virus Kits (QIAGEN)



All employers should be ready to implement strategies to protect their workforce from the Coronavirus while ensuring continuity of operations. The U.S. Chamber of Commerce Foundation created the following documents for businesses based on CDC recommendations.

Further guidance from the State of Michigan can be found here.


If you're organization is staying open during the pandemic, there are measures you can take to help ensure the continued safety and well-being of your employees.

  • Identify possible work-related exposure and heath risks to your employees
  • Train and educate employees about COVID-19
  • Consider flexible work schedules allowing employees to work remotely where possible
  • Socialize a practice of no hand-shaking
  • For meetings of 15 or more, consider virtual or remote gatherings
  • Provide hand santizer at key touch points (copy machines, doors, etc). Have a policy for frequent hand washing
  • Increase cleaning procedures of frequently touched surfaces
  • Remember - employee mental health during times of stress can be a factor in their productivity - increase your mental health services if possible, clarify PTO and sick leave pollicies, and understand that employees will be impacted by school closures and lack of child care services



Symptoms of COVID-19 include fever, cough and shortness of breath. If you are showing signs of Coronavirus, especially if you have known contact with an infected person, stay home and call your doctor for guidance.



Older adults and those of all ages with underlying health conditions - like heart disease, lung diseases, and diabetes - seem to be at higher risk of developing serious COVID-19 illness.


In addition to adhering to the "Stay Home, Stay Safe" policy issued by Governor Whitmer, you can help prevent yourself from getting infected by following basic disease prevention measures including:

  • Wash your hands often with soap and water. If soap is not available, use hand sanitizer with 60% alcohol content or higher
  • Avoid touching your eyes, nose, and mouth with unwashed hands
  • Cover your mouth and nose with a tissue when coughing. If not available, cough into your elbow to avoid spreading germs to your hands
  • Avoid contact with people who are sick
  • Stay home if you are sick and contact your healthcare provide


There are no medications specifically approved for Coronavirus at this time. People infected with COVID-19 should receive supportive care to help relieve symptoms. For severe cases, treatment should include care to support vital organ function.

Creating Value
by delivering business-critical resources & bottom line savings
Building Networks
by connecting Michigan's bio-industry one member at a time
Growing Talent
by creating opportunities that develop people & build organizations
Membership Software Powered by YourMembership  ::  Legal